Product Code: ETC4471650 | Publication Date: Jul 2023 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
The Cardiac Marker Testing market in the Philippines is centered around the diagnosis and monitoring of heart-related conditions. Cardiac markers are proteins or chemicals released into the bloodstream during heart damage. These tests are crucial for diag
The cardiac marker testing market is expanding in response to the rising prevalence of cardiovascular diseases and the need for early diagnosis. These tests are crucial for assessing cardiac health and risk stratification. The integration of cardiac marke
The Philippines Cardiac Marker Testing Market faces challenges related to the prevalence of cardiovascular diseases and the need for early detection. Cardiovascular diseases are a leading cause of morbidity and mortality in the Philippines. However, there
The COVID-19 pandemic heightened the importance of cardiac marker testing, especially for COVID-19 patients at risk of cardiac complications. This market saw an increase in demand for troponin, B-type natriuretic peptide (BNP), and other cardiac markers,
In the Philippines Cardiac Marker Testing market, major diagnostic companies such as Siemens Healthineers, Roche Diagnostics, and Abbott Laboratories lead the way. They offer a comprehensive portfolio of cardiac marker tests and analyzers, which are cruci
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Cardiac Marker Testing Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Philippines Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Philippines Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Philippines Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Philippines Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Philippines Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Philippines Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Cardiac Marker Testing Market Trends |
6 Philippines Cardiac Marker Testing Market, By Types |
6.1 Philippines Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Philippines Cardiac Marker Testing Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Philippines Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.4 Philippines Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Philippines Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Philippines Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Philippines Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Philippines Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Philippines Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Philippines Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Philippines Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Philippines Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Philippines Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Philippines Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Philippines Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Philippines Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Philippines Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Philippines Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Philippines Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Philippines Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Philippines Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Philippines Cardiac Marker Testing Market Export to Major Countries |
7.2 Philippines Cardiac Marker Testing Market Imports from Major Countries |
8 Philippines Cardiac Marker Testing Market Key Performance Indicators |
9 Philippines Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Philippines Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Philippines Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Philippines Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Philippines Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Philippines Cardiac Marker Testing Market - Competitive Landscape |
10.1 Philippines Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Philippines Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |